On January 1, 2017, the ARTA Retiree Benefits Plan will implement a change to the benefit plan that impacts the way we manage drug special authorization requests for members being treated for chronic hepatitis C, Crohn’s disease and colitis, multiple sclerosis, psoriasis and rheumatoid arthritis.
Enhanced Special Authorization Request Forms
If you require special authorization for a specialty drug used to treat a condition outside of the five covered by the enhanced special authorization process (e.g. ankylosing spondylitis, psoriatic arthritis, cancer, hemophilia, blepharospasms, etc.), your physician will manage this process for you. There are no ARTA Retiree Benefits Plan forms to be completed. Simply discuss your condition and treatment options with your physician and they will request approval for you. Your physician will have access to all of the necessary paperwork in order to submit this request.
View our information package below.